Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery

Acta Anaesthesiologica Scandinavica

Volumn 47, Issue 6, 2003, Pages 687-692

  Åvall, Anders ^a   Hyllner, M ^a   Bengtson, J P ^a   Carlsson, L ^a   Bengtsson, A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autologous blood transfusion; Erythropoietin; Hip; Reticulocytes; Surgery

Indexed keywords

BILIRUBIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; HAPTOGLOBIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLEEDING; BLOOD AUTOTRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; LEUKOCYTE COUNT; MALE; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZATION; RETICULOCYTE COUNT; THROMBOCYTE COUNT; TOTAL HIP PROSTHESIS; VITAMIN BLOOD LEVEL;

ADULT; AGED; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD TRANSFUSION, AUTOLOGOUS; ERYTHROPOIETIN; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMATOCRIT; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; RETICULOCYTE COUNT; TIME FACTORS;

EID: 0038545442     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2003.00130.x     Document Type: Article

References (24)

1. Chun T, Martin S, Lepor H. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology 1997: 50: 727-32.
2. Goldberg MA. Perioperative epoetin alfa increases red cell blood mass and reduces exposure to transfusions: Results of randomized clinical trials. Semin Hematol 1997: 34(3 Suppl. 2): 41-7.
3. Mercuriali F. Epoetin alfa increases the Volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. Semin Hematol 1997: 33(2 Suppl. 2): 10-2.
4. Milbrink J, Birgegård G, Danersund A, Helmers C, Nordström L, Sandhagen B. Preoperative autologous donation of 6 units of blood during rh-EPO treatment. Can J Anaesth 1997: 44: 1315-8.
5. Levine E, Rosen A, Sehgal L, Gould S, Sehgal H, Moss G. Accelerated erythropoiesis: the hidden benefit of autologous donation. Transfusion 1990: 30: 295-7.
6. Tasaki T, Hitoshi O, Hashimoto C, Rikiya A, Akira S, Shinichi K. Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production. Lancet 1992: 339: 773-5.
7. de Andrade JB, Jove M, Landon G, Frei D, Guilfoyle M, Young DC. Baseline haemoglobin as a predictor of risk of transfusion and response to epoetin alfa in orthopedic surgery patients. Am J Orthop 1996: 25: 533-42.
8. Walpoth B, Galliker B, Spirig P et al. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery. Semin Hematol 1996: 33(2 Suppl. 2): 75-7.
9. Nydegger U. Enhanced efficacy of autologous blood donation with epoetin alfa. Semin Hematol 1996: 33(2 Suppl. 2): 39-42.
10. Sans T, Bofill C, Joven J et al. Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery. Transfusion 1996: 36: 822-6.
11. Baudoux E. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients. Semin Hematol 1996: 33(2 Suppl. 2): 31-3.
12. Mercuriali F, Zanella A, Barosi G et al. Use of erythropoietin to increase the Volume of autologous blood donated by orthopedic patients. Transfusion 1993: 33(1): 55-60.
13. Goodnough LT, Price TH, Friedman KD et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994: 34(1): 66-71.
14. Cazenave JP, Irrmann C, Waller C et al. Epoetin alfa facilitates presurgical autologous blood donation in non-anaemic patients scheduled for orthopaedic or cardiovascular surgery. Eur J Anaesthesiol 1997: 14(4): 432-42.
15. Stowell CP, Chandler H, Jove M, Guilfoyle M, Wacholtz MC. An open-label, randomised study to compare the safety and efficacy of perioperative autologous blood donation in total joint arthroplasty. Orthopedics 1999: 22(1 Suppl.): 105-12.
16. Olijhoek G, Megens JG, Musto P et al. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomised, placebo-controlled trial. Transfusion 2001: 41(7): 957-63.
17. Feagan BG, Wong CJ, Lau CY, Wheeler SL, Sue-A-Quan G, Kirkley A. Transfusion practice in elective orthopaedic surgery. Transfus Med 2001: 11: 87-95.
18. Hyllner M, Avall A, Swolin B, Bengtson JP, Bengtsson A. Autologous blood transfusion in radical hysterectomy with and without erythropoietin therapy. Obstet Gynecol 2002: 99: 757-62.
19. Canadian Orthopedic Perioperative Erythropoietin Study Group. Effectiveness of perioperative recombinant human erythropoietin in elective hip replacement. Lancet 1993: 341: 1227-32.
20. Erslev AJ. Erythropoietin. N Engl J Med 1991: 324: 1339-44.
21. Lorentz A, Jendrissek A, Eckardt KU, Schipplick M, Osswald PM, Kurtz A. Serial immunoreactive erythropoietin levels in autologous blood donors. Transfusion 1991: 31: 650-4.
22. Biesma DH, Kraaijenhagen RJ, Marx JJM, van de Wiel A. The efficacy of subcutaneous recombinant human erythropoietin in the correction of phlebotomy-induced anemia in autologous blood donors. Transfusion 1993: 33: 825-9.
23. Adamson JW. Regulation of red blood cell production. Am J Med 1996: 101(Suppl. 2A): 4S-6S.
24. Biesma DH, Kraaijenhagen RJ, Poortman J, Marx JJM, van de Wiel A. The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion 1992: 32: 162-5.